Analysis of Blood Banking Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,800.00
This 68-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, ...
September 2012
68 pages
Analysis of Blood Banking Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 114 pages
September 2012
114 pages
Analysis of Cancer Diagnostic Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...
September 2012
185 pages
Analysis of Flow Cytometry Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,280.00
This 40-page report reviews current instrumentation technologies, and compares features of leading flow cytometry analyzers. The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry analyzers and consumables, including their sales, product portfolios, ...
September 2012
40 pages
Analysis of Molecular Diagnostics Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, ...
September 2012
103 pages
Analysis of Emerging Immunodiagnostic Tests And Strategic Profiles of Leading Suppliers
US$ 3,160.00
... of companies developing or marketing new technologies and products. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new ...
September 2012
240 pages
Analysis of Emerging Hemostasis Tests And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... . The report also includes strategic assessments of current and emerging suppliers of hemostasis diagnostic products, including marketing tactics, technological know-how ... pages and 19 tables Synopsis "This 165-page report presents the clinical significance and market needs for major hemostasis laboratory ...
September 2012
165 pages
Analysis of Emerging Microbiology Tests and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... of companies developing or marketing innovative technologies and products. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new ...
September 2012
760 pages
Analysis of Emerging Tumor Markers and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing or ...
September 2012
286 pages
Analysis of Emerging Coagulation Tests and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... companies developing or marketing new coagulation technologies and products. The report also includes strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. ...
September 2012
165 pages
Future Horizons in the European Coagulation Testing Market--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tests by Country
US$ 14,800.00
... business opportunities emerging in the coagulation market during the next five years. The report explores business and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides estimates of the test volume, as well as sales and market shares of leading competitors; ...
September 2012
500 pages
Future Horizons in the European Clinical Chemistry and Immunodiagnostics Markets--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM
US$ 14,800.00
... and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major ...
September 2012
900 pages
Future Horizons in the European Hematology and Flow Cytometry Markets--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tests by Country
US$ 14,800.00
... hematology and flow cytometry markets during the next five years. The report explores future marketing and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of leading ...
September 2012
450 pages
Akzo Nobel: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
The strategic assessment of Akzo Nobel, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the ...
September 2012
45 pages
BASF: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market. Contains 57 pages and 10 tables
September 2012
57 pages
Bayer: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 66 pages and 17 tables
September 2012
66 pages
Dow: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 59 pages and 5 tables
September 2012
59 pages
DuPont: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 59 pages and 7 tables
September 2012
59 pages
Firmenich: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 47 pages and 5 tables
September 2012
47 pages
Givaudan: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 50 pages and 6 tables
September 2012
50 pages
IFF: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 65 pages and 8 tables
September 2012
65 pages
Kansai Paint: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
The strategic assessment of Kansai Paint, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the ...
September 2012
31 pages
